Silence Therapeutics plc (SLNCF)
OTCMKTS · Delayed Price · Currency is USD
1.600
0.00 (0.00%)
Jul 23, 2025, 8:00 PM EDT
Silence Therapeutics Revenue
Silence Therapeutics had revenue of $142.00K in the quarter ending March 31, 2025, a decrease of -99.10%. This brings the company's revenue in the last twelve months to $27.70M, down -16.00% year-over-year. In the year 2024, Silence Therapeutics had annual revenue of $43.26M with 36.71% growth.
Revenue (ttm)
27.70M
Revenue Growth
-16.00%
P/S Ratio
10.81
Revenue / Employee
238.80K
Employees
116
Market Cap
299.44M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 43.26M | 11.62M | 36.71% |
Dec 31, 2023 | 31.64M | 9.99M | 46.12% |
Dec 31, 2022 | 21.66M | 4.84M | 28.82% |
Dec 31, 2021 | 16.81M | 9.33M | 124.73% |
Dec 31, 2020 | 7.48M | 7.16M | 2,214.81% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 84.04M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
BioStem Technologies | 332.45M |
Silence Therapeutics News
- 6 weeks ago - Silence Therapeutics Presents Additional Phase 1 Data Highlighting Promise of Divesiran as the Potential First-in-Class siRNA Treatment for Polycythemia Vera - Business Wire
- 2 months ago - Silence Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights - Business Wire
- 2 months ago - Silence Therapeutics Welcomes Tim McInerney to Board of Directors - Business Wire
- 5 months ago - Silence Therapeutics to Webcast Presentation at the Leerink Partners Global Healthcare Conference - Business Wire
- 5 months ago - Silence Therapeutics plc (SLN) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Silence Therapeutics plc 2024 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 5 months ago - Silence Therapeutics PLC (SLNCF) Reports Full Year 2024 Financial Results with Strong Cash ... - GuruFocus
- 5 months ago - Silence Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update - Business Wire